ClinicalTrials.govpublic full text
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
multiple myeloma, cancer, t(11;14)-positive multiple myeloma, venetoclax, lenalidomide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862660
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.